Shanghai Fosun Pharmaceutical Raises Stake in United Health Insurance; Shares Rise
Shanghai Fosun Pharmaceutical (Group) (HKG:2196) signed a Share Subscription Agreement with IFC and ADB to invest 270 million yuan each in United Health Insurance, according to a Monday filing with the Hong Kong bourse.
The deal will increase Fosun Pharma's stake in the insurer from 14.00% to 20.05%. The capital infusion, totaling 810 million yuan, will support the company's expansion. The transaction does not require the approval of independent shareholders.
Fosun Pharma views this investment as a strategic move to enhance its presence in China's rapidly growing health insurance sector.
The pharmaceuticals shares were up 6% in Hong Kong and 4% in Shanghai in recent trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.